Aug. 16, 2020

Winship Invest$ names pilot grant awardees

Photo of Winship Invest$ names pilot grant awardees

Ten Winship investigators will receive $600,000 in funding for cancer research projects through Winship Invest$.

Ten Winship investigators will receive a total of $600,000 in funding for new cancer research projects through Winship Invest$.

Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research, is supported by philanthropic contributions as well as developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute of the National Institutes of Health.

Winship Invest$ has two funding cycles every year. The most recent call for proposals included a focus on projects that address four strategic areas: (1) community outreach and engagement; (2) gastrointestinal cancer; (3) investigator-initiated clinical trials, and; (4) team science-based research.

This cycle's Winship Invest$ pilot grant recipients are:

  • Multiplexed imaging of tumor microenvironment changes induced by metformin alone and combined
    Mehmet Akce, MD
  • Evaluation of a preclinical model of spontaneous lung cancer metastasis to bone.
    George R. Beck Jr., PhD
  • Examining multilevel barriers and facilitators to implementation of evidence-based risk-stratified mammography screening guideline
    Yue Guan, MB, PhD, ScM
  • Delineating the Impact of Interleukin-37 on the Function of Endogenous and Chimeric Antigen Receptor T-cells in Aged Backgrounds
    Curtis Henry, PhD
  • Exposure to Air Pollutant Mixtures and Incidence of Childhood Cancer
    Anke Huels, PhD
  • Fibroblasts as mediators of metastasis and immune suppression in pancreatic cancer
    Gregory Lesinski, PhD, MPH
  • Targeting immuno-suppressive Siglec15 to improve CAR T cell anti-tumor efficacy
    Sarwish Rafiq, PhD
  • Investigating glutamate dehydrogenase I (GLUD1) as a biomarker and facilitator of venetoclax sensitivity in multiple myeloma
    Mala Shanmugam, PhD, MS
  • Pilot study of psilocybin-assisted therapy combined with multidisciplinary palliative care on demoralization, chronic pain, and flourishing in cancer survivors
    Ali Zarrabi, MD
  • Comprehensive characterization of lung cancer distant metastasis and immune response in a genetically defined mouse model (renewal)
    Adam Marcus, PhD
    Wei Zhou, PhD

For more info, contact:

Cascade Link  TOP